Lenvatinb Clinical Trials

1 actively recruiting trial

Top Sponsors

Sun Yat-sen University1

Indications

Liver Disease1
Systemic Therapy1
Ablation1
Local Therapy1
Recurrent Hepatocellular Carcinoma1

Other1 trial

The Comparison of TACE-Lenvatinib With TACE-Lenvatinib-ablation for Intermediate Recurrent Hepatocellular Carcinoma

N/A

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.